Federation Des Caisses Desjardins Du Quebec Ac Immune Sa Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Aug 30, 2024	SELL	$4.47 - $5.58 $34,615 - $43,211	-7,744 Closed	0 $0
Q1 2020 Aug 30, 2024	BUY	$4.24 - $9.89 $32,834 - $76,588	7,744 New	7,744 $54.1 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.9M

Call Options Held

150K

Put Options Held

12.4K

Bvf Inc San Francisco, CA

19.5M
Shares

$54.5 Million
2.35% of portfolio
Black Rock Inc. New York, NY

2.61M
Shares

$7.27 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

1.69M
Shares

$4.73 Million
0.42% of portfolio
Wells Fargo & Company San Francisco, CA

1.11M
Shares

$3.09 Million
0.0% of portfolio
Platinum Investment Management LTD Sydney Australia 2000, C3

952K
Shares

$2.66 Million
0.17% of portfolio

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $233M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account